company background image
BHC logo

Bausch Health Companies NYSE:BHC Stock Report

Last Price

US$7.53

Market Cap

US$2.8b

7D

-2.0%

1Y

-1.7%

Updated

24 Dec, 2024

Data

Company Financials +

Bausch Health Companies Inc.

NYSE:BHC Stock Report

Market Cap: US$2.8b

BHC Stock Overview

Operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. More details

BHC fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Bausch Health Companies Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bausch Health Companies
Historical stock prices
Current Share PriceUS$7.53
52 Week HighUS$11.46
52 Week LowUS$3.96
Beta0.69
1 Month Change-5.52%
3 Month Change-6.23%
1 Year Change-1.70%
3 Year Change-73.28%
5 Year Change-74.83%
Change since IPO1,406.00%

Recent News & Updates

Bausch Health Companies: Improving Core Business Cures Its Bankruptcy Rumors

Dec 03

Recent updates

Bausch Health Companies: Improving Core Business Cures Its Bankruptcy Rumors

Dec 03

There's No Escaping Bausch Health Companies Inc.'s (NYSE:BHC) Muted Revenues Despite A 28% Share Price Rise

Oct 10
There's No Escaping Bausch Health Companies Inc.'s (NYSE:BHC) Muted Revenues Despite A 28% Share Price Rise

Sale Rumors Lift Both Bausch + Lomb And Parent Bausch Health - A Breakthrough Is Likely

Sep 19

Investors Don't See Light At End Of Bausch Health Companies Inc.'s (NYSE:BHC) Tunnel And Push Stock Down 28%

Aug 06
Investors Don't See Light At End Of Bausch Health Companies Inc.'s (NYSE:BHC) Tunnel And Push Stock Down 28%

2 Red Alerts On Bausch Health Companies

Jul 25

The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

May 21
The Market Doesn't Like What It Sees From Bausch Health Companies Inc.'s (NYSE:BHC) Revenues Yet As Shares Tumble 25%

Why Bausch Health Stock Plunged After Posting First-Quarter 2024 Results

May 07

Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation

Feb 24

Bausch Health: $20bn Debt Is A Mighty Elephant In The Room

Nov 30

Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Nov 01
Does Bausch Health Companies (NYSE:BHC) Have A Healthy Balance Sheet?

Bausch Health's Debt Dilemma: Strategic Decisions And Financial Metrics

Sep 24

Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Jul 24
Is Bausch Health Companies (NYSE:BHC) A Risky Investment?

Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistakes

Jul 06

What To Do After Bausch Health Stock Plunged By Nearly 9% Again

Jun 07

Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Apr 18
Bausch Health Companies (NYSE:BHC) Has No Shortage Of Debt

Bausch Health: A Basket Case Of A Business Only A Hedge Fund Can Bail Out

Dec 30

Bausch Health acne lotion Arazlo available in Canada under public drug plans

Dec 22

Bausch Health: Things To Consider Before Investing

Dec 11

Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Nov 10
Bausch Health Companies (NYSE:BHC) Strong Profits May Be Masking Some Underlying Issues

Bausch Health Companies Q3 2022 Earnings Preview

Nov 02

Shareholder Returns

BHCUS PharmaceuticalsUS Market
7D-2.0%1.6%-2.2%
1Y-1.7%9.7%23.9%

Return vs Industry: BHC underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.

Return vs Market: BHC underperformed the US Market which returned 23.9% over the past year.

Price Volatility

Is BHC's price volatile compared to industry and market?
BHC volatility
BHC Average Weekly Movement6.7%
Pharmaceuticals Industry Average Movement10.4%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: BHC has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: BHC's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a20,270Tom Appiowww.bauschhealth.com

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.

Bausch Health Companies Inc. Fundamentals Summary

How do Bausch Health Companies's earnings and revenue compare to its market cap?
BHC fundamental statistics
Market capUS$2.77b
Earnings (TTM)-US$178.00m
Revenue (TTM)US$9.47b

0.3x

P/S Ratio

-15.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BHC income statement (TTM)
RevenueUS$9.47b
Cost of RevenueUS$2.76b
Gross ProfitUS$6.71b
Other ExpensesUS$6.89b
Earnings-US$178.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.48
Gross Margin70.87%
Net Profit Margin-1.88%
Debt/Equity Ratio-8,887.2%

How did BHC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 21:37
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bausch Health Companies Inc. is covered by 46 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuAegis Capital Corporation
Douglas TsaoBarclays
Ardalan ArfaeiBMO Capital Markets Equity Research